Papers - KISHIMOTO Taishiro

Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials.

Kishimoto T, Robenzadeh A, Leucht C, Leucht S, Watanabe K, Mimura M, Borenstein M, Kane JM, Correll CU

Schizophr Bull 40 ( (1) ) 192 - 213 2014.01

Research paper (scientific journal), Joint Work, Accepted

• Access to Document (DOI)

New developments in the early recognition of individuals at risk for or with emerging schizophrenia and bipolar spectrum disorders.

Correll C, Kishimoto T, Loewy R, Kane JM

(Early Intervention in Psychiatry)  8 ( 29 ) 29 2014

Joint Work

Early nonresponse determined by the clinical global impressions scale predicts poorer outcomes in youth with schizophrenia spectrum disorders naturalistically treated with second-generation antipsychotics.

Stentebjerg-Olesen M, Jeppesen P, Pagsberg AK, Fink-Jensen A, Kapoor S, Chekuri R, Carbon M, Al-Jadiri A, Kishimoto T, Kane JM, Correll CU

J Child Adolesc Psychopharmacol. 23 ( (10) ) 665 - 675 2013.12

Research paper (scientific journal), Joint Work, Accepted

• Access to Document (DOI)

Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials

Nitta M, Kishimoto T, Müller N, Weiser M, Davidson M, Kane JM, Correll CU

Schizophr Bull 39 ( (6) ) 1230 - 1241 2013.11

Research paper (scientific journal), Joint Work, Accepted

• Access to Document (DOI)

An open-label study of algorithm-based treatment versus treatment-as-usual for patients with schizophrenia

Hirano J, Watanabe K, Suzuki T, Uchida H, Den R, Kishimoto T, Nagasawa T, Tomita Y, Hara K, Ochi H, Kobayashi Y, Ishii M, Fujita A, Kanai Y, Goto M, Hayashi H, Inamura K, Ooshima F, Sumida M, Ozawa T, Sekigawa K, Nagaoka M, Yoshimura K, Konishi M, Inagaki A, Saito T, Motohashi N, Mimura M, Okubo Y, Kato M

Neuropsychiatr Dis Treat 9   1553 - 1564 2013.10

Research paper (scientific journal), Joint Work, Accepted

• Access to Document (DOI)

Long Acting Injectable vs. Oral Antipsychotics in Schizophrenia: A Systematic Review and Meta-Analysis of Mirror-Image Studies

Kishimoto T, Nitta M, Borenstein M, Kane JM, Correll CU

J Clin Psychiatry 74 ( (10) ) 957 - 965 2013.10

Research paper (scientific journal), Joint Work, Accepted

• Access to Document (DOI)

Antipsychotic polypharmacy: a Japanese survey of prescribers' attitudes and rationales

Kishimoto T, Watanabe K, Uchida H, Mimura M, Kane JM, Correll CU.

Psychiatry Res 209 ( (3) ) 406 - 411 2013.10

Research paper (scientific journal), Joint Work, Accepted

• Access to Document (DOI)

Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies

Kane JM, Kishimoto T, Correll CU

World Psychiatry 12 ( (3) ) 216 - 226 2013.10

Research paper (scientific journal), Joint Work

• Access to Document (DOI)

Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry

Kane JM, Kishimoto T, Correll CU

J Clin Epidemiol 66 ( (8 Suppl) ) S37 - S41 2013.08

Research paper (scientific journal), Joint Work, Accepted

• Access to Document (DOI)

The impact of prolactin-raising antipsychotics on bone mineral density in patients with schizophrenia: findings from a longitudinal observational cohort

Takahashi T, Uchida H, John M, Hirano J, Watanabe K, Mimura M, Correll CU, Kishimoto T

Schizophr Res 147 ( (2-3) ) 383 - 386 2013.07

Research paper (scientific journal), Joint Work, Accepted

• Access to Document (DOI)

Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics

Kishimoto T, Agarwal V, Broday A, Kishi T, Geiman G, Kane JM, Correll C.

Mol Psychiatry 18 ( (1) ) 53 - 66 2013.01

Research paper (scientific journal), Joint Work, Accepted

• Access to Document (DOI)

The 3rd Schizophrenia International Research Society Conference, 14-18 April 2012, Florence, Italy: summaries of oral sessions.

Abbs B, Achalia RM, Adelufosi AO, Aktener AY, Beveridge NJ, Bhakta SG, Blackman RK, Bora E, Byun MS, Cabanis M, Carrion R, Castellani CA, Chow TJ, Dmitrzak-Weglarz M, Gayer-Anderson C, Gomes FV, Haut K, Hori H, Kantrowitz JT, Kishimoto T, Lee FH, Lin A, Palaniyappan L, Quan M, Rubio MD, Ruiz de Azúa S, Sahoo S, Strauss GP, Szczepankiewicz A, Thompson AD, Trotta A, Tully LM, Uchida H, Velthorst E, Young JW, O'Shea A, Delisi LE

Schizophr Res 141 ( (1) ) e1 - e24 2012.10

Research paper (scientific journal), Joint Work, Accepted

• Access to Document (DOI)

Osteoporosis and fracture risk in people with schizophrenia.

Kishimoto T, De Hert M, Carlson HE, Manu P, Correll CU.

Curr Opin Psychiatry 25 ( (5) ) 415 - 429 2012.09

Research paper (scientific journal), Joint Work, Accepted

• Access to Document (DOI)

Antipsychotic polypharmacy: A survey study of prescriber attitudes, knowledge and behavior.

Correll CU, Shaikh L, Gallego JA, Nachbar J, Olshanskiy V, Kishimoto T, Kane JM

Schizophr Res 131 ( (1-3) ) 58 - 62 2011.05

Research paper (scientific journal), Joint Work, Accepted

• Access to Document (DOI)

Quantifying clinical relevance in the treatment of schizophrenia

Correll CU, Kishimoto T, Nielson J, Kane JM

Clinical therapeutics 33 ( (12) ) B16 - B39 2011

Research paper (scientific journal), Joint Work, Accepted

• Access to Document (DOI)

Randomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternatives.

Correll CU, Kishimoto T, Kane JM

Dialogues Clin Neurosci. 13 ( (2) ) 155 - 172 2011

Research paper (scientific journal), Joint Work, Accepted

Review: most antipsychotic drugs more than double the prolactin levels in children and adolescents.

''Correll C, Kishimoto T, Carlson H.

Evid Based Ment Health. 13 ( (2) ) 54 2010.05

Research paper (scientific journal), Joint Work, Accepted

• Access to Document (DOI)

Antipsychotic-induced hyperprolactinemia inhibits the hypothalamo-pituitary-gonadal axis and reduces bone mineral density in male patients with schizophrenia

Kishimoto T, Watanabe K, Shimada N, Makita K, Yagi G, Kashima H

J Clin Psychiatry 69 ( (3) ) 385 - 391 2008.03

Research paper (scientific journal), Joint Work, Accepted

Bone mineral density measurement in female inpatients with schizophrenia.

Kishimoto T, Watanabe K, Takeuchi H, Kikuchi T, Nakajima S, Shimada N, Yagi G, Kashima H

Schizophr Res 77 ( 1 ) 113 - 115 2005.09

Research paper (scientific journal), Accepted

PCCX1, a novel　DNA-binding protein with PHD finger and CXXC domain, is regulated by proteolysis.

Fujino T, Hasegawa M, Shibata S, Kishimoto T, Imai S, Takano T

Biochem Biophys Res Commun 271 ( (2) ) 305 - 310 2000.05

Research paper (scientific journal), Accepted

• Access to Document (DOI)